Literature DB >> 8737698

A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery.

F C Riess1, B Pötzsch, R Bader, N Bleese, A Greinacher, C Löwer, K Madlener, G Müller-Berghaus.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8737698     DOI： 10.1016/s1010-7940(96)80100-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN： 1010-7940            Impact factor:   4.191


× No keyword cloud information.
  4 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  The emergency use of recombinant hirudin in cardiopulmonary bypass. 1999.

Authors:  Nicklett Johnston; Michael E Jessen; Michael DiMaio; Debra S Douglass
Journal:  J Extra Corpor Technol       Date:  2005-09

Review 3.  Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

4.  Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.

Authors:  Haralabos Parissis
Journal:  J Cardiothorac Surg       Date:  2011-04-08       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.